http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3111930-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b318488a74b02429f1ea9726eb403e47
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-201
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076
filingDate 2016-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b10111cbb823e4267e4585ca817c0d10
publicationDate 2017-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3111930-A3
titleOfInvention Composition for treating depression, bipolar disorders, recurrent medical depressive disorders and other long-term affective disorders
abstract The present invention relates to a composition for the treatment of depression and other persistent affective disorders comprising at least four components of (i) a hyperforin-containing component, (ii) a kavapyrone and / or rosavin-containing component, (iii) a linalool and linalyl acetate containing component, (iv) an S-adenosylmethionine-containing component and (v) a linoleic acid and linolenic acid-containing component, and optionally additionally an amino acid complex.
priorityDate 2015-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014348883-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010002406-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012177732-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20110134961-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9803170-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010133377-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006282509-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6549
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226474246
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441298
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409845

Total number of triples: 44.